Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
This study has been completed.
Study NCT00629200 Information provided by M.D. Anderson Cancer Center
First Received on February 25, 2008. Last Updated on November 21, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Cancer
Solid Tumors
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
Sodium Stibogluconate
Interferon Alpha-2b
Additional drug interventions recognized in this trial
Antimony Sodium Gluconate
Interferon Alfa-2a
Interferon Alfa-2b
Interferon-alpha
Interferons
Reaferon
More general drug interventions related to this trial
Adjuvants, Immunologic
Alcohol Deterrents
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anthelmintics
Anti-Infective Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Antiviral Agents
Central Nervous System Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
VioQuest Pharmaceuticals
Back to top of Main Content
